| Product Code: ETC7660416 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Quinolones Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Quinolones Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Quinolones Market - Industry Life Cycle |
3.4 Israel Quinolones Market - Porter's Five Forces |
3.5 Israel Quinolones Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Israel Quinolones Market Revenues & Volume Share, By Pathogen Type, 2021 & 2031F |
3.7 Israel Quinolones Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Israel Quinolones Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Israel Quinolones Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Israel Quinolones Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Quinolones Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Israel |
4.2.2 Growing awareness about the effectiveness of quinolones in treating various infections |
4.2.3 Rise in healthcare expenditure and investments in healthcare infrastructure in Israel |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines for the use of antibiotics, including quinolones |
4.3.2 Emergence of antibiotic resistance leading to decreased efficacy of quinolones |
5 Israel Quinolones Market Trends |
6 Israel Quinolones Market, By Types |
6.1 Israel Quinolones Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Quinolones Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Israel Quinolones Market Revenues & Volume, By Urinary Tract Infection, 2021- 2031F |
6.1.4 Israel Quinolones Market Revenues & Volume, By Intra-Abdominal Infections, 2021- 2031F |
6.1.5 Israel Quinolones Market Revenues & Volume, By Blood Stream Infections, 2021- 2031F |
6.1.6 Israel Quinolones Market Revenues & Volume, By Clostridium Difficile Infections, 2021- 2031F |
6.2 Israel Quinolones Market, By Pathogen Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Quinolones Market Revenues & Volume, By Gram-Positive Pathogen, 2021- 2031F |
6.2.3 Israel Quinolones Market Revenues & Volume, By Gram-Negative Pathogen, 2021- 2031F |
6.3 Israel Quinolones Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Israel Quinolones Market Revenues & Volume, By Lomefloxacin, 2021- 2031F |
6.3.3 Israel Quinolones Market Revenues & Volume, By Gatifloxacin, 2021- 2031F |
6.3.4 Israel Quinolones Market Revenues & Volume, By Norfloxacin, 2021- 2031F |
6.3.5 Israel Quinolones Market Revenues & Volume, By Moxifloxacin, 2021- 2031F |
6.3.6 Israel Quinolones Market Revenues & Volume, By Ciprofloxacin, 2021- 2031F |
6.4 Israel Quinolones Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Quinolones Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Israel Quinolones Market Revenues & Volume, By Injectable, 2021- 2031F |
6.5 Israel Quinolones Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Israel Quinolones Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Israel Quinolones Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Israel Quinolones Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6 Israel Quinolones Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Quinolones Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Israel Quinolones Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 Israel Quinolones Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Israel Quinolones Market Import-Export Trade Statistics |
7.1 Israel Quinolones Market Export to Major Countries |
7.2 Israel Quinolones Market Imports from Major Countries |
8 Israel Quinolones Market Key Performance Indicators |
8.1 Percentage increase in prescriptions of quinolones by healthcare providers in Israel |
8.2 Number of clinical studies demonstrating the efficacy of quinolones in treating different types of infections |
8.3 Percentage of patients reporting positive outcomes and satisfaction with quinolone treatment |
9 Israel Quinolones Market - Opportunity Assessment |
9.1 Israel Quinolones Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Israel Quinolones Market Opportunity Assessment, By Pathogen Type, 2021 & 2031F |
9.3 Israel Quinolones Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Israel Quinolones Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Israel Quinolones Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 Israel Quinolones Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Quinolones Market - Competitive Landscape |
10.1 Israel Quinolones Market Revenue Share, By Companies, 2024 |
10.2 Israel Quinolones Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here